StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for PRA yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $24.65 | $24.51 | -0.57% | 1.7M |
| 05-18 | $24.52 | $24.62 | +0.41% | 1.3M |
| 05-19 | $24.58 | $24.66 | +0.33% | 0.9M |
| 05-20 | $24.68 | $24.60 | -0.32% | 0.8M |
| 05-21 | $24.60 | $24.62 | +0.08% | 0.5M |
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $262.63M | $1.10B | $828.38M | $548.83M |
Operating Income | $9.19M | $72.07M | $25.47M | $21.10M |
Net Income | $8.46M | $50.91M | $17.55M | $16.10M |
EPS (Diluted) | $0.16 | $0.99 | $0.34 | $0.31 |
Total Assets | $5.41B | $5.45B | $5.55B | $5.49B |
Total Liabilities | $4.08B | $4.10B | $4.25B | $4.21B |
Cash & Equivalents | $14.05M | $36.49M | $54.46M | $41.60M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 51.81M | 51.41M | 51.63M | 51.56M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.